首页 | 本学科首页   官方微博 | 高级检索  
     

意义不明确的不典型鳞状细胞中检测高危型HPV的价值
引用本文:何善阳,袁力,姚书忠,杨炜敏,游泽山. 意义不明确的不典型鳞状细胞中检测高危型HPV的价值[J]. 中国妇产科临床杂志, 2011, 12(1): 3-6. DOI: 10.3969/j.issn.1672-1861.2011.01.002
作者姓名:何善阳  袁力  姚书忠  杨炜敏  游泽山
作者单位:中山大学附属第一医院妇产科,广州,510080
摘    要:目的探讨在意义不明确的不典型鳞状细胞(ASCUS)中检测HR-HPV,预测宫颈上皮内瘤样病变及浸润癌的诊断价值。方法对宫颈薄层液基细胞学诊断为ASCUS的248例患者分别进行HR-HPV检测、阴道镜下活组织检查。结果在ASCUS患者中,CIN发生率为41.1%(102/248),高级别CIN(CIN2、CIN3)和浸润癌发生率为9.3%(23/248);在HR-HPV阳性组CIN检出率为68.1%(92/135),在HR-HPV阴性组CIN检出率为8.8%(10/113),两组间差异有统计学意义(χ2=89.330,P〈0.001)。阳性组发生CIN和浸润癌的风险是阴性组的22.037倍[OR(95%CI)=22.037(10.479~46.342)]。HR-HPV检测CIN和浸润癌的敏感度和特异度分别为68.1%和91.2%;阳性预测值和阴性预测分别为90.1%和70.5%。阴道镜拟诊CIN和浸润癌126例,检出率为80.4%(82/102),其中高级别CIN和浸润癌20例,检出率为87.0%(20/23);阴道镜检测CIN和浸润癌的敏感度和特异度分别为65.1%和83.6%;阳性预测值和阴性预测分别为80.4%和69.9%,与HR-HPV检测功效相似,关联系数为r=0.833;而阴道镜检测高级别CIN和浸润癌的敏感度和特异度分别为80.0%和98.7%;阳性预测值和阴性预测值分别为87.0%和97.8%。结论 HR-HPV阳性的ASCUS患者CIN发生率高,即行阴道镜检查;HR-HPV阴性患者可不行阴道镜检查而不会增加高级别CIN和浸润癌发生风险。

关 键 词:高危型人乳头状瘤病毒  意义不明确的不典型鳞状细胞  宫颈上皮内瘤样病变  阴道镜

The value of human papillomavirus testing in atypical squamous cell of undetermined significance
HE Shanyang,YUAN Li,YAO Shuzhong,YANG Weimin,YOU Zeshan. The value of human papillomavirus testing in atypical squamous cell of undetermined significance[J]. Chinese Journal of Clinical Obstetrics and Gynecology, 2011, 12(1): 3-6. DOI: 10.3969/j.issn.1672-1861.2011.01.002
Authors:HE Shanyang  YUAN Li  YAO Shuzhong  YANG Weimin  YOU Zeshan
Affiliation:HE Shanyang,YUAN Li,YAO Shuzhong,YANG Weimin,YOU Zeshan.(Department of Obstetrics and Gynecology,Huangpu Hospital of The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510700,China)
Abstract:Objective To investigate the significance of high-risk HPV(HR-HPV) testing in atypical squamous cell of undetermined significance(ASCUS),so as to predict cervical intraepithelial neoplasia (CIN) and invasive cancer.Methods A total of 248 patients with ASCUS tested by thin-prep-1iquid-based cytology were undergone with HR-HPV testing,colposcopy and cervical biopsies. Results Incidence of CIN,high level CIN(CIN2、CIN3) and invasive carcinoma was 41.1% (102/248)and 9.3% (23/248),respectively. The positive rate of HR-HPV test was 54.4% (135/248). The frequency of CIN in HR-HPV positive group and negative group was 68.1% (92/135) and 8.8% (10/113). The difference was statistically significant(χ2=89.330,P<0.001).Incidence of CIN and invasive carcinoma in HR-HPV-positive group was about 22 fold of that in HR-HPV-negative grouyp [OR(95% CI)= 22.037(10.479~46.342 )].The sensitivity and specificity of HR-HPV test in diagnosing CIN and invasive carcinoma were 68.1% and 91.1%. Positive predictive value and negative predictive value was 90.1% and 70.5%,respectively. There were 126 cases with CIN and invasive cancer diagnosed by colposcopy. The detection rate was 80.4% (82/102),of which 20 cases of high-level CIN and invasive cancer was diagnosed with detection rate of 87.0%(20/23). The sensitivity and specificity were 65.1% and 83.6% in diagnosing CIN and invasive carcinoma by colposcopy and the negative predictive value and positive predictive were 80.4% and 69.9%. The sensitivity and specificity of HR-HPV-positive in diagnosing high level CIN (CIN2~ CIN3) and invasive carcinoma by colposcopy were 80.0% and 98.7%,the positive predictive value and negative predictive value was 87.0% and 97.7%.Conclusion Patients with ASCUS and HR-HPV positive have high incidence of CIN that immediate colposcopy was essential for them.
Keywords:HR-HPV  ASCUS  CIN  colposcopy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号